Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02969356 · ClinicalTrials.gov registry record · Phase 4
Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)
A Phase 4 study, sponsored by Ipsen.
- Completed
- Registry status
- Phase 4
- Development phase
- 157
- Enrollment target
NCT02969356 is a Phase 4 study that has completed, run by Ipsen. The registered enrollment target is 157 participants.
The verdict
NCT02969356, a Phase 4 study, has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 157 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to assess whether AbobotulinumtoxinA (Dysport®) injections in upper and lower limbs accompanied with a personal exercise plan called "Guided Self-rehabilitation Contract" (GSC) can improve voluntary movements in subjects with hemiparesis.
Interventions
- BIOLOGICAL Botulinum toxin type A
- OTHER GSC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2016-12-18 |
| Est. Completion | 2018-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02969356
The ClinicalTrials.gov registry entry for NCT02969356 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Botulinum toxin type A is the first listed.
NCT02969356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02969356 about?
NCT02969356 is a clinical study titled "Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)". The purpose of this clinical study is to assess whether AbobotulinumtoxinA (Dysport®) injections in upper and lower limbs accompanied with a personal exercise plan called "Guided Self-rehabilitation Contract" (GSC) can improve voluntary movements in subjects with hemiparesis.
What is the current status of trial NCT02969356?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 157 participants. The study started on 2016-12-18. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02969356?
The interventions under investigation include: Botulinum toxin type A (BIOLOGICAL), GSC (OTHER).
Who is sponsoring clinical trial NCT02969356?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.